2018
DOI: 10.1016/j.hlc.2017.06.722
|View full text |Cite
|
Sign up to set email alerts
|

Trends and Clinical Outcomes in Patients Undergoing Primary Percutaneous Revascularisation for ST-Elevation Myocardial Infarction: A Single Centre Experience

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
0
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 35 publications
1
0
0
Order By: Relevance
“…Over the same time period, the age-adjusted 28-day and 1-year mortality rates for STEMI have not improved despite the documented increase in coronary angiography and revascularisation, the transition to more use of routine primary PCI and the other management advances in common with NSTEMI management. These trends are similar to other contemporary studies, although our absolute 28-day mortality rates were significantly higher because those studies contained only patients with STEMI who underwent PCI whereas we included all patients with STEMI admitted to New Zealand hospitals regardless of management disposition 28 29. One reason for this trend is that approximately two-thirds of the deaths included in 1-year mortality occurred within 28 days, compared with approximately one-third for NSTEMI, and early deaths are more difficult to reduce, particularly with medical therapy advances which take time to show efficacy.…”
Section: Discussionsupporting
confidence: 74%
“…Over the same time period, the age-adjusted 28-day and 1-year mortality rates for STEMI have not improved despite the documented increase in coronary angiography and revascularisation, the transition to more use of routine primary PCI and the other management advances in common with NSTEMI management. These trends are similar to other contemporary studies, although our absolute 28-day mortality rates were significantly higher because those studies contained only patients with STEMI who underwent PCI whereas we included all patients with STEMI admitted to New Zealand hospitals regardless of management disposition 28 29. One reason for this trend is that approximately two-thirds of the deaths included in 1-year mortality occurred within 28 days, compared with approximately one-third for NSTEMI, and early deaths are more difficult to reduce, particularly with medical therapy advances which take time to show efficacy.…”
Section: Discussionsupporting
confidence: 74%